Latest Insider Transactions at Moelis & CO (MC)
This section provides a real-time view of insider transactions for Moelis & CO (MC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Moelis & Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Moelis & Co's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 02
2022
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
2
+0.89%
|
-
|
Dec 02
2022
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
25
+1.27%
|
-
|
Dec 02
2022
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
19
+1.31%
|
-
|
Dec 02
2022
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
12
+1.22%
|
-
|
Dec 02
2022
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
24
+1.31%
|
-
|
Dec 02
2022
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
18
+1.28%
|
-
|
Dec 02
2022
|
Yolonda C Richardson Director |
BUY
Grant, award, or other acquisition
|
Direct |
24
+1.31%
|
-
|
Dec 02
2022
|
Yolonda C Richardson Director |
BUY
Grant, award, or other acquisition
|
Direct |
18
+1.28%
|
-
|
Nov 16
2022
|
Kenneth Moelis Chairman, CEO |
SELL
Open market or private sale
|
Indirect |
10,253
-5.03%
|
$461,385
$45.55 P/Share
|
Nov 15
2022
|
Kenneth Moelis Chairman, CEO |
SELL
Open market or private sale
|
Indirect |
100,000
-32.93%
|
$4,600,000
$46.74 P/Share
|
Nov 14
2022
|
Joseph Simon Former Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
12,370
-75.84%
|
$556,650
$45.98 P/Share
|
Nov 14
2022
|
Kenneth Moelis Chairman, CEO |
SELL
Open market or private sale
|
Direct |
82,921
-38.73%
|
$3,814,366
$46.02 P/Share
|
Nov 04
2022
|
Eric Cantor Vice Chairman, MD |
SELL
Payment of exercise price or tax liability
|
Direct |
1,263
-0.87%
|
$49,257
$39.92 P/Share
|
Nov 04
2022
|
Eric Cantor Vice Chairman, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
1,263
+0.86%
|
-
|
Nov 03
2022
|
Eric Cantor Vice Chairman, MD |
SELL
Payment of exercise price or tax liability
|
Direct |
822
-0.57%
|
$35,346
$43.01 P/Share
|
Nov 03
2022
|
Eric Cantor Vice Chairman, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
1,868
+1.27%
|
-
|
Aug 23
2022
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
3
+1.02%
|
-
|
Aug 23
2022
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
25
+1.29%
|
-
|
Aug 23
2022
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
18
+1.26%
|
-
|
Aug 23
2022
|
Yolonda C Richardson Director |
BUY
Grant, award, or other acquisition
|
Direct |
23
+1.27%
|
-
|
Aug 23
2022
|
Yolonda C Richardson Director |
BUY
Grant, award, or other acquisition
|
Direct |
18
+1.3%
|
-
|
Aug 23
2022
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
16
+1.24%
|
-
|
Aug 23
2022
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
23
+1.27%
|
-
|
Aug 23
2022
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
18
+1.3%
|
-
|
Jul 28
2022
|
Kenneth Moelis Chairman, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
27
+0.02%
|
-
|
Jul 28
2022
|
Eric Cantor Vice Chairman, MD |
SELL
Payment of exercise price or tax liability
|
Direct |
832
-0.58%
|
$35,776
$43.93 P/Share
|
Jul 28
2022
|
Eric Cantor Vice Chairman, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
1,891
+1.29%
|
-
|
Jul 01
2022
|
Yolonda C Richardson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,760
+50.0%
|
-
|
Jul 01
2022
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
289
+50.0%
|
-
|
Jul 01
2022
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
1,885
+50.0%
|
-
|
Jul 01
2022
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
1,257
+50.0%
|
-
|
Jul 01
2022
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
1,760
+50.0%
|
-
|
Jun 21
2022
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
12
+16.67%
|
-
|
Jun 21
2022
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
43
+3.0%
|
-
|
Jun 08
2022
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
3
+1.23%
|
-
|
Jun 08
2022
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
17
+1.24%
|
-
|
Jun 08
2022
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
20
+1.27%
|
-
|
Jun 08
2022
|
Yolonda C Richardson Director |
BUY
Grant, award, or other acquisition
|
Direct |
17
+1.24%
|
-
|
Jun 08
2022
|
Yolonda C Richardson Director |
BUY
Grant, award, or other acquisition
|
Direct |
20
+1.27%
|
-
|
Jun 08
2022
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
0
|
-
|
Jun 08
2022
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
17
+1.24%
|
-
|
Jun 08
2022
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
20
+1.27%
|
-
|
May 31
2022
|
Elizabeth Crain |
SELL
Open market or private sale
|
Direct |
7,000
-100.0%
|
$329,000
$47.08 P/Share
|
May 25
2022
|
Elizabeth Crain |
SELL
Open market or private sale
|
Direct |
7,116
-50.41%
|
$313,104
$44.61 P/Share
|
Apr 28
2022
|
Eric Cantor Vice Chairman, MD |
SELL
Payment of exercise price or tax liability
|
Direct |
4,799
-3.26%
|
$211,156
$44.88 P/Share
|
Apr 28
2022
|
Eric Cantor Vice Chairman, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
10,460
+6.64%
|
-
|
Mar 28
2022
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
6
+1.24%
|
-
|
Mar 28
2022
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
16
+1.19%
|
-
|
Mar 28
2022
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
19
+1.22%
|
-
|
Mar 28
2022
|
Yolonda C Richardson Director |
BUY
Grant, award, or other acquisition
|
Direct |
16
+1.19%
|
-
|